Epsilon M&A Deal Report - Delpharm
Transaction Multiples for the Valuation of Private Companies
OBO led by Delpharm's Chairman with IFE Mezzanine / Delpharm
No EMAT :
73810
Announced Date :
24/06/2011
Type :
OBO (Owner Buy Out) ,Exit
Deal Value :
Yes
Acquirer :
OBO led by Delpharm's Chairman with IFE Mezzanine
Target :
Delpharm
Country :
France
Sector of activity :
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
Business Description :
Founded in 1988, Delpharm SAS provides contract manufacturing services for pharmaceutical products . > Offers under license products, generics, OTC products, dietary supplements, and veterinary...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
||||||
| Current |
|
|
|
|
ns |
Rating :
*
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Pharmaceuticals » = 128
| Date | Acquirer | Target | Country | Multiples | See details |
| 29/05/2013 | Anjac | CH-Pharma (Laboratoires Chemineau) | Indre-Et-Loire | ** | 73776 |
| 19/11/2013 | Private Group led by 21 Partners | SynerLAB | France | * | 73752 |
Source: Epsilon Research / EMAT
